orexigen
Fat-fighting pharma business files for bankruptcy
March 15, 2018Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical
Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …
FDA issued the fewest warnings over pharma advertising this year since 1997
December 11, 2017Sales and Marketing Amherst, FDA, advertising, cipher, orexigen, pharma
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …
Weight loss pill treatment rejected by NICE
May 8, 2017Medical Communications, Sales and Marketing NICE, orexigen
NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …
Orexigen and Takeda reboot Contrave collaboration
August 12, 2015Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs
Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …
Takeda hits major snags with Contrave and Alisertib
May 14, 2015Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen
Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …
Chiesi gets first-ever European stem cell nod
December 19, 2014Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen
Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …
Sanofi to produce weight-loss drug for Orexigen
November 11, 2013Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen
Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …
Orexigen’s chief executive elected to PhRMA Board
April 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen
Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
